ReWalk Robotics Ltd (RWLK)

[Chas42va]

Agree with your near term Revenue estimate of $140 million but your valuation is too conservative. Many more avenues of revenue increases based on the needs of population with FDA and EU Approval in hand

Also you presume Price to Sales ratio of 1:1 - 140 million Mkt cap / 140 million Sales divided by 6 million shares outstanding is $23 per share.

P to S of 3to1 ( very reasonable) is more like $60+ per share —current is 5to1

Also the gross profit margin is quite excellent at about 50% so earnings to follow sales

This is an excellent BUYOUT candidate for medical device company - it will not last long given the high TAM (total addressable market)
Needs.